Validation of the calibrated thrombin generation test (cTGT) as the reference assay to evaluate the procoagulant activity of nanomaterials

Nanotoxicology

Volumn 6, Issue 2, 2012, Pages 213-232

  Laloy, Julie ^a   Robert, Séverine ^a   Marbehant, Catherine ^a   Mullier, François ^a,b   Mejia, Jorge ^a,c   Piret, Jean Pascal ^a   Lucas, Stéphane ^a   Chatelain, Bernard ^b   Dogné, Jean Michel ^a   Toussaint, Olivier ^a   Masereel, Bernard ^a   Rolin, Stéphanie ^a  

^a University of Namur   (Belgium)

^b UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^c UNIVERSITY OF NAMUR   (Belgium)

Author keywords

Coagulation cascade; Nanoparticles; Procoagulant activity; Thrombin generation; Toxicity

Indexed keywords

CARBON; COPPER OXIDE; NANOMATERIAL; NANOPARTICLE; POLOXAMER; SILICON CARBIDE; SILICON DIOXIDE; TITANIUM CARBIDE;

ADULT; ARTICLE; ASSAY; BLOOD CLOTTING; BLOOD CLOTTING TIME; CALIBRATION; FEMALE; HUMAN; MALE; PHYSICAL CHEMISTRY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SUSPENSION; THROMBIN TIME; TOXICITY TESTING; VALIDATION PROCESS;

ADOLESCENT; ADULT; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CALIBRATION; COAGULANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NANOSTRUCTURES; POLOXAMER; REPRODUCIBILITY OF RESULTS; THROMBIN; THROMBOPLASTIN; TOXICITY TESTS;

EID: 84856675929     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2011.569096     Document Type: Article

References (57)

1. Amelung. 1993. Technical Manual of KC4. Germany: Amelung.
2. Baglin T. 2005. The measurement and application of thrombin generation. Br J Haematol 130(5):653-661. (Pubitemid 43906639)
3. Barlow PG, Donaldson K,MacCallum J, Clouter A, Stone V. 2005. Serum exposed to nanoparticle carbon black displays increased potential to induce macrophage migration. Toxicol Lett 155(3):397-401. (Pubitemid 40093003)
4. Chan WC, Nie S. 1998. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281(5385):2016-2018. (Pubitemid 28475486)
5. Cherukuri P, Gannon CJ, Leeuw TK, Schmidt HK, Smalley RE, Curley SA, Weisman RB. 2006. Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence. Proc Natl Acad Sci USA 103(50):18882-18886. (Pubitemid 350002796)
6. Corey JM, Gertz CC, Sutton TJ, Chen Q, Mycek KB, Wang B, Martin AA, Johnson SL, Feldman EL. 2009. Patterini N-type and S-type neuroblastoma cells with Pluronic F108 and ECM proteins. J Biomed Materials Res A 90A(3):673-686.
7. Decuzzi P, Pasqualini R, Arap W, Ferrari M. 2009. Intravascular delivery of particulate systems: Does geometry really matter? Pharm Res 26(1):235-243.
8. Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE. 2008. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 5(4):487-495.
9. Dobrovolskaia MA, Patri AK, Zheng J, Clogston JD, Ayub N, Aggarwal P, Neun BW, Hall JB, McNeil SE. 2009. Interaction of colloidal gold nanoparticles with human blood: Effects on particle size and analysis of plasma protein binding profiles. Nanomedicine 5(2):106-117.
10. Donaldson K, Tran CL. 2002. Inflammation caused by particles and fibers. Inhal Toxicol 14:5-27. (Pubitemid 34094358)
11. Emmerechts J, Alfaro-Moreno E, Vanaudenaerde BM, Nemery B, Hoylaerts MF. 2010. Short-term exposure to particulate matter induces arterial but not venous thrombosis in healthy mice. J Thromb Haemost 8(12):2651-2661.
12. Ferrari M. 2005. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5(3):161-171. (Pubitemid 40314948)
13. Geng Y, Dalhaimer P, Cai S, Tsai R, Tewari M, Minko T, Discher DE. 2007. Shape effects of filaments versus spherical particles inflowanddrugdelivery. NatNanotechnol 2(4):249-255. (Pubitemid 46739812)
14. Gorbet MB, Sefton MV. 2004. Biomaterial-associated thrombosis: Roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 25(26):5681-5703. (Pubitemid 38624449)
15. Hemker HC, Al Dieri R, De Smedt E, Beguin S. 2006. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 96(5):553-561. (Pubitemid 44782533)
16. Hemker HC, Beguin S. 1999. Endogenous thrombin potential. In: Laboratory techniques in thrombosis. A manual. Dordrecht: Kluwer Academic Publishers. pp 63-78.
17. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Beguin S. 2003. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 33(1):4-15. (Pubitemid 37449290)
18. Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Beguin S. 2002. The calibrated automated thrombogram (CAT): A universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 32(5-6):249-253. (Pubitemid 37490547)
19. Hong J, Andersson J, Ekdahl KN, Elgue G, Axen N, Larsson R, Nilsson B. 1999. Titanium is a highly thrombogenic biomaterial: Possible implications for osteogenesis. Thromb Haemost 82(1):58-64. (Pubitemid 29368774)
20. Jiang J, Oberdörster G, Biswas P. 2009. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. Journal of Nanopart Res 11(1):77-89.
21. Jun EA, Lim KM, Kim K, Bae ON, Noh JY, Chung KH, Chung JH. 2010. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity. Nanotoxicology (DOI 10.3109/17435390.2010.506250) (Epub ahead of print).
22. Liang XJ, Chen C, Zhao Y, Jia L, Wang PC. 2008. Biopharmaceutics and therapeutic potential of engineered nanomaterials. Curr Drug Metab 9(8):697-709.
23. Lynch I, Dawsons KA. 2008. Protein-nanoparticles interactions. Nanotoday 3:40-47.
24. Mackman N. 2008. Triggers, targets and treatments for thrombosis. Nature 451(7181):914-918.
25. Mayer A, Vadon M, Rinner B, Novak A, Wintersteiger R, Frohlich E. 2009. The role of nanoparticle size in hemocompatibility. Toxicology 258(2-3):139-147.
26. McGuigan AP, Sefton MV. 2007. The influence of biomaterials on endothelial cell thrombogenicity. Biomaterials 28(16):25 47-2571.
27. Mejia J, Tichelaar F, Saout C, Toussaint O, Masereel B, Mekhalif Z, Lucas S, Delhalle J. 2010. Effects of the dispersion methods in Pluronic F108 on the size and the surface composition of MWCNTs and their implications in toxicology assessment. Journal of Nanopart Res 13(2): 655-667.
28. Nadler M, Mahrholz T, Riedel U, Schilde C, Kwade A. 2008. Preparation of colloidal carbon nanotube dispersions and their characterisation using a disc centrifuge. Carbon 48:1384-1392.
29. Nel AE, Madler L, Velegol D, Xia T, Hoek EM, Somasundaran P, Klaessig F, Castranova V, Thompson M. 2009. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8(7):543-557.
30. Nemmar A, Hoet PH, Dinsdale D, Vermylen J, Hoylaerts MF, Nemery B. 2003a. Diesel exhaust particles in lung acutely enhance experimental peripheral thrombosis. Circulation 107(8):1202-1208. (Pubitemid 36297215)
31. Nemmar A, Hoylaerts MF, Hoet PH, Dinsdale D, Smith T, Xu H, Vermylen J, Nemery B. 2002. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med 166(7):998-1004. (Pubitemid 35193233)
32. Nemmar A, Hoylaerts MF, Hoet PH, Nemery B. 2004. Possible mechanisms of the cardiovascular effects of inhaled particles: Systemic translocation and prothrombotic effects. Toxicol Lett 149(1-3):243-253. (Pubitemid 38469842)
33. Nemmar A, Hoylaerts MF, Hoet PH, Vermylen J, Nemery B. 2003b. Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. Toxicol Appl Pharmacol 186(1):38-45. (Pubitemid 36262947)
34. Nemmar A, Nemery B, Hoet PH, Vermylen J, Hoylaerts MF. 2003c. Pulmonary inflammation and thrombogenicity caused by diesel particles in hamsters: Role of histamine. Am J Respir Crit Care Med 168(11):1366-1372. (Pubitemid 37487333)
35. Nie S, Xing Y, Kim GJ, Simons JW. 2007. Nanotechnology applications in cancer. Annu Rev Biomed Eng 9:257-288. (Pubitemid 350246658)
36. Nishiyama N. 2007. Nanomedicine: Nanocarriers shape up for long life. Nat Nanotechnol 2(4):203-204. (Pubitemid 46739817)
37. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, et al. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Part Fibre Toxicol 2:8.
38. Patel DN, Bailey S.R. 2007. Nanotechnology in cardiovascular medicine. Catheter Cardiovasc Interv 69(5):643-654. (Pubitemid 46581252)
39. Pelzer H, Schwarz A, Heimburger N. 1988. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 59(1):101-106. (Pubitemid 18053658)
40. Piret JP, Detriche S, Vigneron R, Vankoningsloo S, Rolin S, Mejia Mendoza JH, Masereel B, Lucas S, Delhalle J, Luizi F, et al. 2010a. Dispersion of multi-walled carbon nanotubes in biocompatible dispersants. J Nanopart Res 12(1):75-82.
41. Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM. 2006. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci 90(2): 296-303.
42. Radomski A, Jurasz P, Alonso-Escolano D, Drews M, Morandi M, Malinski T, Radomski MW. 2005. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol 146(6):882-893. (Pubitemid 41622255)
43. Renne T, Gailani D. 2007. Role of Factor XII in hemostasis and thrombosis: Clinical implications. Expert Rev Cardiovasc Ther 5(4):733-741. (Pubitemid 47050183)
44. Robert S, Baccelli C, Devel P, Dogne JM, Quetin-Leclercq J. 2010. Effects of leaf extracts from Croton zambesicus Muell. Arg. on hemostasis. J Ethnopharmacol 128(3):641-648.
45. Robert S, Ghiotto J, Pirotte B, David JL, Masereel B, Pochet L, Dogne JM. 2009. Is thrombin generation the new rapid, reliable and relevant pharmacological tool for the development of anticoagulant drugs? Pharmacol Res 59(3):160-166.
46. Seyfert UT, Biehl V, Schenk J. 2002. In vitro hemocompatibility testing of biomaterials according to the ISO 10993-4. Biomol Eng 19(2-6):91-96.
47. Shenoy DB, Amiji MM. 2005. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharm 293(1-2):261-270. (Pubitemid 40381098)
48. Silva VM, Corson N, Elder A, Oberdörster G. 2005. The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP). Toxicol Sci 85(2):983-989. (Pubitemid 40846873)
49. Simak J. 2009. Nanotoxicity in blood: Effects of engineered nanomaterails on platelets. In: Sahu SC, Cascaciano DA, editors. Nanotoxicity: From in vivo and in vitro models to health risks. Chichester: John Wiley & Sons. pp 191-225.
50. Smith SA. 2009. The cell-based model of coagulation. J Vet Emerg Crit Care (San Antonio) 19(1):3-10.
51. Son SJ, Bai X, Lee SB. 2007. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications. Drug Discov Today 12(15-16):650-656. (Pubitemid 47238640)
52. Taurozzi JS, Hackley VA, Wiesner MR. 2010. Ultrasonic dispersion of nanoparticles for environmental, health and safety assessment - issues and recommendations. Nanotoxicology (DOI 10.3109/17435390.2010.528846) (Epub ahead of print).
53. Van den Besselaar AMHP, Neuteboom J, Meewisse-Braun J, Bertina RM. 1997. Preparation of lyophilized partial thromboplastin time reagent composed of synthetic phospholipids: Usefulness for monitoring heparin therapy. Clin Chem 43(7):1215-1222. (Pubitemid 27297266)
54. Vankoningsloo S, Piret JP, Saout C, Noel F, Mejia J, Zouboulis CC, Delhalle J, Lucas S, Toussaint O. 2010. Cytotoxicity of multi-walled carbon nanotubes in three skin cellular models: Effects of sonication, dispersive agents and corneous layer of reconstructed epidermis. Nanotoxicology 4(1):84-97.
55. Wang L, Wang K, Santra S, Zhao X, Hilliard LR, Smith JE, Wu Y, Tan W. 2006. Watching silica nanoparticles glow in the biological world. Anal Chem 78(3):646-654. (Pubitemid 43228570)
56. Wang RK, Park HO, Chen WC, Silvera-Batista C, Reeves RD, Butler JE, Ziegler KJ. 2008. Improving the effectiveness of interfacial trapping in removing single-walled carbon nanotube bundles. J Am Chem Soc 130(44):14721-14728.
57. Zuo L, WeiW,Morris M, Wei J, Gorbounov M, Wei C. 2007. New technology and clinical applications of nanomedicine. Med Clin North Am 91(5):845-862. (Pubitemid 47361207)